Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate Risk Non-Muscle Invasive Bladder Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06108492
What this trial is testing

A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Intermediate and High-risk Non-muscle Invasive Bladder Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd. 170
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06829823
What this trial is testing

Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
ImmunityBio, Inc. 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05024734
What this trial is testing

Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids

Who this might be right for
Bladder CancerNon-muscle Invasive
Roland Seiler-Blarer 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07777848
What this trial is testing

Evaluate the Efficacy and Safety of RAG-01 as Monotherapy and in Combination With Chemotherapy in Patients With Non-muscle Invasive Bladder Cancer (NMIBC).

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Ractigen Therapeutics. 114
Large-scale testing (Phase 3)Ended earlyNCT03224182
What this trial is testing

Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Participants Undergoing Transurethral Resection of Bladder Tumor (TURBT)

Who this might be right for
Bladder Cancer
Spectrum Pharmaceuticals, Inc 118
Large-scale testing (Phase 3)Study completedNCT05136898
What this trial is testing

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Bladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder
UroGen Pharma Ltd. 8
Large-scale testing (Phase 3)Looking for participantsNCT06441110
What this trial is testing

Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer

Who this might be right for
Urinary Bladder NeoplasmsBCG VaccineImmunotherapy, Active+3 more
Fujian Medical University Union Hospital 76
Large-scale testing (Phase 3)Looking for participantsNCT05037279
What this trial is testing

Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)

Who this might be right for
Bladder CancerBladder Cancer RecurrentNeoplasm Recurrence+3 more
Verity Pharmaceuticals Inc. 540
Testing effectiveness (Phase 2)Study completedNCT00192049
What this trial is testing

Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer

Who this might be right for
Superficial Bladder Cancer
Eli Lilly and Company 90
Large-scale testing (Phase 3)UnknownNCT04736394
What this trial is testing

Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC Patients

Who this might be right for
Non-muscle Invasive Bladder Cancer
Jiangsu Yahong Meditech Co., Ltd aka Asieris 800
Not applicableUnknownNCT06403202
What this trial is testing

Prognostic Performance of a Chemogram in Patients With Bladder Cancer.

Who this might be right for
Urinary Bladder Neoplasms
Lille Catholic University 60
Not applicableStudy completedNCT04885309
What this trial is testing

Efficacy and Safety of Obturator Nerve Block During Transurethral Resection on Non-muscle Invasive Intermediate and High Risk Lateral Wall Bladder Tumours

Who this might be right for
Bladder Cancer Stage 0Bladder Cancer Stage I
Ankara Training and Research Hospital 104
Not applicableActive Not RecruitingNCT07391137
What this trial is testing

CRUCIAL-R Study : Cruciferous Vegetables Dietary Regimen in NMIBC

Who this might be right for
Recurrence Free SurvivalBladder Cancer Recurrence
S. Andrea Hospital 250
Not applicableStudy completedNCT03694535
What this trial is testing

Intravesical Thermochemotherapy With Mitomycin-c

Who this might be right for
Bladder Cancer
TC Erciyes University 44
Testing effectiveness (Phase 2)Study completedNCT02197897
What this trial is testing

Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors

Who this might be right for
Bladder Cancer
Baylor College of Medicine 15
Large-scale testing (Phase 3)Looking for participantsNCT06319820
What this trial is testing

Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC 641
Large-scale testing (Phase 3)Ended earlyNCT01469221
What this trial is testing

Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Bladder Cancer
Spectrum Pharmaceuticals, Inc 47
Not applicableLooking for participantsNCT04564781
What this trial is testing

Predicting BCG Response

Who this might be right for
Bladder Cancer
Cedars-Sinai Medical Center 400
Large-scale testing (Phase 3)Active Not RecruitingNCT06331299
What this trial is testing

UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder
UroGen Pharma Ltd. 99
Large-scale testing (Phase 3)UnknownNCT04490993
What this trial is testing

Safety and Efficacy of APL-1202 in Combination With Epirubicin Hydrochloride Versus Epirubicin Hydrochloride Alone in Intermediate and High-risk Chemo-refractory Non-muscle Invasive Bladder Cancer (NMIBC) Patients

Who this might be right for
Non-muscle Invasive Bladder Cancer
Jiangsu Yahong Meditech Co., Ltd aka Asieris 359
Next Page